Aurinia Q2 2026: LUPKYNIS Sales Surge 19% to $79.4M, Net Income Hits $37.4M
AUPH sits 52% above its 52-week low of $10.34.
Summary
Aurinia's Q2 2026 results show LUPKYNIS sales accelerating to $79.4M (+19% YoY), net income of $37.4M, and strong cash generation. The Kezar acquisition closed, and the balance sheet remains robust with $443M in cash and investments.
Key Events · Earnings and Guidance · AUPH
-
LUPKYNIS Sales Growth Accelerates
Net product sales of $79.4M in Q2 2026, up 19% from $66.6M in Q2 2025, driven by deeper lupus nephritis market penetration.
-
Net Income More Than Doubles
Net income of $37.4M ($0.28 diluted EPS) vs $21.5M ($0.16) in Q2 2025, reflecting revenue growth and operating expense discipline.
-
Cash Generation Strengthens
Operating cash flow of $85.1M in H1 2026, up 87% YoY. Cash and investments totaled $443.1M at quarter-end, up from $398.0M at year-end 2025.
-
Kezar Acquisition Closed
Completed acquisition of Kezar Life Sciences on May 11, 2026 for $55.5M total consideration, adding aritinercept pipeline and $23.1M in deferred tax benefits.
Analysis · AUPH · Life Sciences
Aurinia delivered a strong quarter with LUPKYNIS net product sales up 19% year-over-year to $79.4 million, driving total revenue to $83.2 million. Net income reached $37.4 million, a 74% increase from the prior year, as operating leverage improved. The company generated $85.1 million in operating cash flow in the first half, ending the quarter with $443.1 million in cash and investments. The acquisition of Kezar Life Sciences closed in May, adding a pipeline asset and deferred tax benefits. The results confirm the commercial momentum of LUPKYNIS and a strengthening financial position, though the normalized tax rate now reflects full cash tax payments going forward.
At the time of this filing, AUPH was trading at $15.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $10.34 to $19.25. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.